Bladder cancer, Transitional cell cancer
Results
Phase 2
This trial looked at atezolizumab for people whose bladder cancer had spread beyond the inner lining of the bladder, but not to another area of the body.
Recruitment start: 1 May 2016
Recruitment end: 30 June 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Thomas Powles
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
F. Hoffmann-La Roche Ltd
Queen Mary University of London
This is the Cancer Research UK trial number CRUKE/15/014.
Last reviewed: 12 Mar 2021
CRUK internal database number: 13385
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
